New Management Strategy of Pregnancies at Risk of Congenital Adrenal Hyperplasia Using Fetal Sex Determination in Maternal Serum: French Cohort of 258 Cases (2002–2011)
The DOI matches its Crossref record; 40 of the 44 references it cites were found in a registry or an index.
Abstract
CONTEXT: Prenatal dexamethasone (DEX) treatment has been proposed since 1984 to prevent genital virilization in girls with congenital adrenal hyperplasia (CAH). DEX is effective in CAH females if initiated before the sixth week of gestation, but its safety in children treated in utero remains controversial regarding cognitive functions. OBJECTIVE: To avoid prenatal DEX in males and initiate DEX in due time in CAH females, we proposed in 2002 a protocol for fetal sex determination in the maternal serum (SRY test). DESIGN AND SETTING: We conducted a retrospective study of the management of 258 fetuses in the period 2002 through 2011 in pregnancies managed in referent medical centers with an institutional practice. PATIENTS: A total of 258 fetuses at risk of CAH (134 males and 124 females) were included. INTERVENTION: DEX was offered after informed consent to pregnant women. MAIN OUTCOME MEASURE: The sensitivity of an early SRY test was evaluated after data collection. RESULTS: The SRY test is sensitive from 4 weeks and 5 days of gestation. It avoided prenatal DEX in 68% of males, and this percentage increased over the years. DEX was maintained until prenatal diagnosis in non-CAH females. Virilization was prevented in 12 CAH girls treated at the latest at 6 weeks gestation and minimized in 3 girls treated between 6 and 7 weeks gestation. Maternal tolerance was correct. No fetal malformations were noted in the 154 children treated in utero. CONCLUSIONS: The SRY test is reliable to avoid prenatal DEX in males, but its application must be improved. Prenatal DEX should be maintained to prevent virilization and traumatic surgery in CAH girls after informed consent and information provided to families about the benefit to risk ratio in limiting hyperandrogenism during fetal life. Our large multicentric French cohort has helped to better assess the risks previously reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In a study of prenatal treatment in 258 fetuses at risk for CAH from 2002 to 2011, testing for Y-chromosome DNA prevented treatment with Dex in only 68% of male fetuses, although the percentage rose during the course of the study (97).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [97]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Unlike fetal cells, it disappears from the maternal circulation shortly after delivery (319,320) and therefore does not confound prenatal genetic investigations in subsequent pregnancies (321,322).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [322]
Experimental — accuracy not yet measuredIn the citing paper
“In a 10-year French study, among 112 treated female fetuses, 14 had 21-hydroxylase-deficient CAH and three had 11-hydroxylase-deficient CAH; of these 17 girls, 12 had normal female genitalia at birth and 3 had moderate virilization, whereas 2 who were treated late were severely virilized (97).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [97]
In the citing paper
“Aside from individual case reports, only two series of prenatal treatment of CAH have appeared since August 2009.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Presence of fetal DNA in maternal plasma and serum
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02174-0 · Cited by 3,129
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Developmental and Functional Biology of the Primate Fetal Adrenal Cortex*
Mesiano, S., & Jaffe, R. B. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0304 · Cited by 680
Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus
Uno, H., Lohmiller, L., Thieme, C., Kemnitz, J. W., Engle, M. J., Roecker, E. B., & Farrell, P. M. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90002-g · Cited by 502
(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Joint LWPES/ESPE CAH Working Group (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020611 · Cited by 332
In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development
Goto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25091 · Cited by 284
New, M. I., Carlson, A., Obeid, J., Marshall, I., Cabrera, M. S., Goseco, A., Lin-Su, K., Putnam, A. S., Wei, J. Q., & Wilson, R. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8072 · Cited by 263
Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency
David, M., & Forest, M. G. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80310-8 · Cited by 256
Self-citationCrouch, N. S., Liao, L. M., Woodhouse, C. R. J., Conway, G. S., & Creighton, S. M. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.09.079 · Cited by 249
Research works printed but not linked: 2
- Gorduza D, Vidal I, Birraux J, et al. The surgical challenges of dis- orders of sex development (DSD). Arch Esp Urol. 2010;63:495- 504.
- Tardy V. Management of pregnancies at risk of 21-hydroxylase or 11-hydroxylase deficiency using fetal sex determination in maternal serum proposed in France since 2002: how to limit prenatal expo- sure to dexamethasone. Horm Res. 2009;70(Suppl 3):348.
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
New, M. I., Tong, Y. K., Yuen, T., Jiang, P., Pina, C., Chan, K. C. A., Khattab, A., Liao, G. J. W., Yau, M., Kim, S.-M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1118 · Cited by 319
“A recent publication by Tardy-Guidollet et al (19) demonstrates their success in using the SRY probe for noninvasive prenatal sex determination.”
Surgery in disorders of sex development (DSD) with a gender issue: If (why), when, and how?
Mouriquand, P. D. E., Gorduza, D. B., Gay, C.-L., Meyer-Bahlburg, H. F. L., Baker, L., Baskin, L. S., Bouvattier, C., Braga, L. H., Caldamone, A. C., Duranteau, L., et al. (2016) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2016.04.001 · Cited by 250
Congenital adrenal hyperplasia
Auer, M. K., Nordenström, A., Lajic, S., & Reisch, N. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01330-7 · Cited by 215
Evolution of steroids during pregnancy: Maternal, placental and fetal synthesis
Morel, Y., Roucher, F., Plotton, I., Goursaud, C., Tardy, V., & Mallet, D. (2016) · Annales d'Endocrinologie · doi:10.1016/j.ando.2016.04.023 · Cited by 119
Self-citationBouvattier, C., Esterle, L., Renoult-Pierre, P., de la Perrière, A. B., Illouz, F., Kerlan, V., Pascal-Vigneron, V., Drui, D., Christin-Maitre, S., Galland, F., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4124 · Cited by 116
“) in the Molecular Laboratory for Rare Endocrine Disorders (Lyon, France), as previously reported (8, 25, 26) Supplemental Table 1.”
BackgroundSelf-citationDisorders of sex development: effect of molecular diagnostics
Achermann, J. C., Domenice, S., Bachega, T. A. S. S., Nishi, M. Y., & Mendonca, B. B. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.69 · Cited by 116
Baumgartner-Parzer, S., Witsch-Baumgartner, M., & Hoeppner, W. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0653-5 · Cited by 110
Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia
Parsa, A. A., & New, M. I. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.015 · Cited by 105
Jenkins, L., Deans, Z. C., Lewis, C., & Allen, S. K. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5197 · Cited by 95
Noninvasive Prenatal Diagnosis of Single-Gene Diseases: The Next Frontier
Scotchman, E., Chandler, N. J., Mellis, R., & Chitty, L. S. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.304238 · Cited by 88
Non-invasive prenatal diagnosis and screening for monogenic disorders
Scotchman, E., Shaw, J., Paternoster, B., Chandler, N. J., & Chitty, L. S. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.08.001 · Cited by 87
Next-generation sequencing and the impact on prenatal diagnosis
Mellis, R., Chandler, N. J., & Chitty, L. S. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1493924 · Cited by 69
Sex-dimorphic effects of prenatal treatment with dexamethasone
Wallensteen, L., Zimmermann, M., Thomsen Sandberg, M., Gezelius, A., Nordenström, A., Hirvikoski, T., & Lajic, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1543 · Cited by 67
“trimester of pregnancy cannot be avoided (4).”
Hanson, B., Scotchman, E., Chitty, L. S., & Chandler, N. J. (2022) · Clinical Science · doi:10.1042/cs20210380 · Cited by 67
Cell‐free fetal DNA: the new tool in fetal medicine
Everett, T. R., & Chitty, L. S. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14746 · Cited by 63
Bachelot, A., Grouthier, V., Courtillot, C., Dulon, J., & Touraine, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0888 · Cited by 57
Johnston, Z. C., Bellingham, M., Filis, P., Soffientini, U., Hough, D., Bhattacharya, S., Simard, M., Hammond, G. L., King, P., O’Shaughnessy, P. J., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1009-7 · Cited by 44
Maternal risks of fetal therapy
Alrefai, A., Ryan, G., & Mieghem, T. V. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000346 · Cited by 43
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura‐Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0009 · Cited by 37
Discordant fetal sex on NIPT and ultrasound
Smet, M.-E., Scott, F., & McLennan, A. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5676 · Cited by 38
Riveline, J., Baz, B., Nguewa, J. L., Vidal-Trécan, T., Ibrahim, F., Boudou, P., Vicaut, É., de la Perrière, A. B., Fetita, L.-S., Bréant, B., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz145 · Cited by 31
Self-citationChallenges in prenatal treatment with dexamethasone
(2018) · PubMed · doi:10.17458/per.vol16.2018.mcpa.dexamethasone · Cited by 30
“retrospective study performed in 2014 showed that the SRY test was sensitive for identifying Y-chromosome material at 4 weeks and 5 days of gestation (37).”
MethodLajić, S., Karlsson, L., & Nordenström, A. (2018) · Hormone Research in Paediatrics · doi:10.1159/000485100 · Cited by 32
Russian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Pediatric Disorders of Sex Development
Achermann, J. C., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00023-x · Cited by 29
White, P. C. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000402 · Cited by 29
Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe
Nowotny, H., Neumann, U., Tardy-Guidollet, V., Ahmed, S. F., Baronio, F., Battelino, T., Bertherat, J. Y., Blankenstein, O., Bonomi, M., Bouvattier, C. M., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-0554 · Cited by 27
Self-citationPregnancy and Prenatal Management of Congenital Adrenal Hyperplasia
Cera, G., Locantore, P., Novizio, R., Maggio, E., Ramunno, V., Corsello, A., Policola, C., Concolino, P., Paragliola, R. M., & Pontecorvi, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206156 · Cited by 27
Prenatal Diagnosis of Congenital Adrenal Hyperplasia
Yau, M., Khattab, A., & New, M. I. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.001 · Cited by 26
Gorduza, D., Tardy-Guidollet, V., Robert, E., Gay, C.-L., Chatelain, P., David, M., Bretones, P., Lienhardt-Roussie, A., Brac de la Perriere, A., Morel, Y., et al. (2014) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2014.02.003 · Cited by 20
Self-citationNoninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia
Khattab, A., Yuen, T., Sun, L., Yau, M., Barhan, A., Zaidi, M., Lo, Y. M. D., & New, M. I. (2015) · Endocrine development · doi:10.1159/000439326 · Cited by 20
Wallensteen, L., Karlsson, L., Messina, V., Nordenström, A., & Lajić, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa280 · Cited by 18
Westeinde, A. V., Karlsson, L., Messina, V., Wallensteen, L., Brösamle, M., Maso, G. D., Lazzerini, A., Kristensen, J. K., Kwast, D., Tschaidse, L., et al. (2023) · Endocrine Connections · doi:10.1530/ec-22-0400 · Cited by 19
Dörr, H. G., Binder, G., Reisch, N., Gembruch, U., Oppelt, P. G., Wieacker, P. F., & Kratzsch, J. (2015) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0041-109717 · Cited by 20
New developments in prenatal diagnosis of congenital adrenal hyperplasia
Kazmi, D., Bailey, J., Yau, M. L., Abu‐Amer, W., Kumar, A., Low, M., & Yuen, T. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.016 · Cited by 17
Heland, S., Hewitt, J. K., McGillivray, G., & Walker, S. P. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12423 · Cited by 16
Non-invasive prenatal diagnosis (NIPD): current and emerging technologies
Hanson, B., Paternoster, B., Povarnitsyn, N., Scotchman, E., Chitty, L. S., & Chandler, N. J. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2022.44 · Cited by 14
Prenatal and Pregnancy Management of Congenital Adrenal Hyperplasia
Nowotny, H. F., Tschaidse, L., Auer, M. K., & Reisch, N. (2024) · Clinical Endocrinology · doi:10.1111/cen.15131 · Cited by 14
Xu, L., Lin, W., Cai, L., Huang, H., Liang, J., Li, L., Zong, L., Wang, N., Wen, J., & Chen, G. (2020) · Clinical Endocrinology · doi:10.1111/cen.14126 · Cited by 12
Concolino, P., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf018 · Cited by 12
Congenital Adrenal Hyperplasia: Unresolved Issues
Yau, M., Khattab, A., Poppas, D. P., Ghizzoni, L., & New, M. I. (2016) · Frontiers of hormone research · doi:10.1159/000443919 · Cited by 12
Congenital Adrenal Hyperplasia
Trapp, C. M., Levine, L. S., & Oberfield, S. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_14 · Cited by 8
Nouveautés dans l’hyperplasie congénitale des surrénales
Dumeige, L., Bouvattier, C. M., & Lombès, M. (2017) · Annales d Endocrinologie · doi:10.1016/s0003-4266(17)30922-8 · Cited by 9
Karlsson, L., Wallensteen, L., Nordenström, A., Krmar, R. T., & Lajić, S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac081 · Cited by 7
Gembruch, U. (2017) · Springer eBooks · doi:10.1007/978-3-662-53662-9_11 · Cited by 7
Abalı, Z. Y., Kurnaz, E., & Güran, T. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-10-s · Cited by 6
Uncertain Knowledge: The Medicalisation of Intersex People and the Production of Ignorance
Raz, M. (2024) · Social Sciences · doi:10.3390/socsci13080385 · Cited by 7
Verebi, C., Gravrand, V., Pacault, M., Audrézet, M., Couque, N., Vincent, M., Leturcq, F., Tsatsaris, V., Bienvenu, T., & Nectoux, J. (2023) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2023.07.005 · Cited by 6
Adrenal Pathologies During Pregnancy and Postpartum
St‐Jean, M., Bourdeau, I., & Lacroix, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00025-8 · Cited by 5
Tardy-Guidollet, V., Menassa, R., Aubry, M. C., & Benachi, A. (2015) · Revue de médecine périnatale · doi:10.1007/s12611-015-0331-y · Cited by 5
Self-citationIn case you missed it: thePrenatal Diagnosiseditors bring you the most significant advances of 2014
Faas, B. H. W., Ghidini, A., Mieghem, T. V., Chitty, L. S., Deprest, J. A., & Bianchi, D. W. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4551 · Cited by 4
CHANDRAN, S. R., & Loh, L. M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1490399 · Cited by 4
Hyperplasie congénitale des surrénales par déficit en 21-hydroxylase
Bachelot, A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75965-9.00012-x · Cited by 4
Carrière, C., Sarfati, C., Téjédor, I., Dulon, J., Chakhtoura, Z., Courtillot, C., & Bachelot, A. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.04.007 · Cited by 3
Problèmes éthiques du dépistage prénatal non invasif (DPNI)
Sann, L. (2016) · Revue de médecine périnatale · doi:10.1007/s12611-016-0351-2 · Cited by 2
Pediatric endocrinology: an overview of the last decade
Ibáñez, L., Barouti, K., Markantes, G. Κ., Armeni, A. K., & Georgopoulos, N. A. (2018) · HORMONES · doi:10.1007/s42000-018-0067-8 · Cited by 2
Prenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia
Abalı, Z. Y., & Güran, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_9 · Cited by 2
Gembruch, U. (2013) · Springer eBooks · doi:10.1007/978-3-642-29633-8_11 · Cited by 2
Prenatal diagnosis of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
Yau, M., Pina, C., Khattab, A., Barhen, A., & New, M. I. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1035254 · Cited by 2
Anomalías de la diferenciación sexual
Tachdjian, G. (2017) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(17)86892-2 · Cited by 1
Has the Era of Individualized Intrauterine Treatment for Congenital Adrenal Hyperplasia Arrived?
Fu, X., Xia, Y., Li, S., Zhao, Z., Kong, L., Zhu, J., Li, H., Wu, S., Wu, D., & Kong, X. (2025) · Prenatal Diagnosis · doi:10.1002/pd.6747 · Cited by 1
Anaforoğlu, İ., & Ertörer, M. E. (2026) · HORMONES · doi:10.1007/s42000-026-00808-w · Cited by 1
Prenatal Diagnosis and Treatment of Genetic Steroid Disorders
Simpson, J. L., Rechitsky, S., Khattab, A., & New, M. I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813570-9.00029-2 · Cited by 1
Noninvasive Prenatal Screening and Diagnosis Using Cell‐free Fetal DNA
Hill, M. K., & Chitty, L. S. (2015) · Wiley eBooks · doi:10.1002/9781118981559.ch11 · Cited by 1
Scotchman, E., Shaw, J., Chandler, N. J., & Chitty, L. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-31758-3_20 · Cited by 1
Speiser, P., & Milunsky, A. (2015) · Wiley eBooks · doi:10.1002/9781118981559.ch27
Test non invasif et diagnostic de sexe fœtal : où en est-on ?
Vivanti, A. J., Benachi, A., & Costa, J. (2016) · Revue de médecine périnatale · doi:10.1007/s12611-016-0357-9
Self-citationNichtklassisches adrenogenitales Syndrom: Diagnose und Therapie
Böttcher, B., & Wildt, L. (2016) · Gynäkologische Endokrinologie · doi:10.1007/s10304-016-0088-9
Prenatal Diagnosis and Treatment of Congenital Adrenal Hyperplasia
Lajić, S., & Nordenström, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65214-5
Fertility and Pregnancy in Patients With 21-Hydroxylase Deficiency
Grouthier, V., Courtillot, C., Dulon, J., Touraine, P. A., & Bachelot, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65342-4
Hyperplasie congénitale des surrénales
Fuzier, V. (2015) · Elsevier eBooks · doi:10.1016/b978-2-294-74764-9.00101-1
21-hydroxylase deficiency and fertility
Amiraslanova, M. M., & Kuznetsova, I. V. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-4-16-26
Noninvasive Prenatal Diagnosis for Single-Gene Disorders
Hill, M. K., & Chitty, L. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-7020-6956-7.00022-1
Noninvasive Prenatal Diagnosis and Screening for Monogenic Disorders Using Cell‐Free DNA
den Veyver, I. B. V., Chandler, N. J., & Chitty, L. S. (2021) · Wiley eBooks · doi:10.1002/9781119676980.ch8
Dexamethasone: Various toxicities: 3 case reports
(2014) · Reactions Weekly · doi:10.1007/s40278-014-5889-9
Diagnóstico prenatal mediante muestra de sangre materna
Vivanti, A. J., Abgral, M., Benachi, A., & Costa, J. (2018) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(18)91439-6
Self-citationMoldenhauer, J. S., Gebb, J. S., & Teefey, C. P. (2022) · Springer eBooks · doi:10.1007/978-3-031-07524-7_9
The impact of genetic steroid disorders on human fertility
Reichman, D. E., Rosenwaks, Z., Perelman, R. O., & Cohen, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00022-8
Debates and controversies in genetic steroid disorders
Speiser, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00014-9
Update on prenatal diagnosis and treatment of congenital adrenal hyperplasia
Westeinde, A. V., Nordenström, A., & Lajić, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00183-7
Fertility and pregnancy in patients with 21 hydroxylase deficiency
Grouthier, V., & Bachelot, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00207-7
Gembruch, U., & Strizek, B. (2025) · Springer eBooks · doi:10.1007/978-3-662-67373-7_11
Hyperplasie congénitale des surrénales : formes précoces
Levaillant, L., Bouhours‐Nouet, N., Rouleau, S., Amsellem‐Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(25)85172-x
Dubey, S., Saxena, R., Kohli, S., Roy, G., Gupta, D., Jaswal, H., Bijarnia‐Mahay, S., & Puri, R. D. (2025) · Genetic Clinics · doi:10.4103/genc.genc_22_25
Diagnostic prénatal par prélèvement de sang maternel
Vivanti, A. J., Abgral, M., Benachi, A., & Costa, J. (2025) · EMC - Obstétrique · doi:10.1016/s0246-0335(25)49943-8
Self-citationHiperplasia suprarrenal congénita: formas precoces
Levaillant, L., Bouhours-Nouet, N., Rouleau, S., Amsellem-Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pediatría · doi:10.1016/s1245-1789(25)51124-1
DöRR, H., Binder, G., REISCH, N., GEMBRUCH, U., OPPELT, P., Wieacker, P., & Kratzsch, J. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21447-9.50058-1
Wu, L., Lin, Y., Gao, B., Zhu, B., Dai, P., & Huang, S. (2026) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2025.12.005
Birch, L. Y. L., & Sferruzzi-Perri, A. N. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00938-1
Reproductive and fertility challenges in adolescents with congenital adrenal hyperplasia
Tschaidse, L., Auer, M. K., Nowotny, H. F., & Reisch, N. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1878713
Giri, D., Alderson, J., Bashir, M., Shalaby, M. S., Williams, C., & Park, J. (2026) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2026-0106
Дефицит 21-гидроксилазы и фертильность
М., А. М., & Н., К. И. (2020) · Medical alphabet
Adrenogenitales Syndrom (AGS) und Hirsutismus
Dervishi, O., & Reisch, N. (2026) · Elsevier eBooks · doi:10.1016/b978-3-437-23857-4.00017-5
Metadata
- Authors
- Tardy-Guidollet, V., Menassa, R., Costa, J.-M., David, M., Bouvattier-Morel, C., Baumann, C., Houang, M., Lorenzini, F., Philip, N., Odent, S., Guichet, A., & Morel, Y.
- Affiliations
- Hospices Civils de Lyon (FR)
- Département de Génétique (J.-M.C), Laboratoire Cerba, 95066 Cergy Pontoise, France;
- Hôpital Femme Mère Enfant (FR)
- Unité d'Endocrinologie pédiatrique (C.B.-M.), Centre Hospitalier de Bicêtre, 94275 Le Kremlin-Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France;
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Armand-Trousseau (FR)
- Hôpital Paule de Viguier (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Département de Génétique (S.O.), Hôpital Sud, 35203 Rennes, France;
- Centre Hospitalier Universitaire d'Angers (FR)
- Corresponding author
- Tardy-Guidollet, Véronique
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-04-01
- Volume
- 99
- Issue
- 4
- Pages
- 1180-1188
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2064123952
- Cited by
- 96
- References
- 44
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 13 · 2017: 7 · 2016: 11 · 2015: 14 · 2014: 4
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- congenital adrenal hyperplasia, prenatal dexamethasone, fetal sex determination, SRY gene, maternal serum, prenatal diagnosis, hyperandrogenism, pregnancy management
- MeSH terms
- Adrenal Hyperplasia, Congenital, Blood Chemical Analysis, Dexamethasone, Female, France, Humans, Male, Maternal-Fetal Exchange, Pregnancy, Prenatal Diagnosis, Risk Factors, Sex Determination Analysis, Virilism, Cohort Studies, Fetal Therapies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.